Course and Predictors of Visual Outcome of Idiopathic Intracranial Hypertension
- PMID: 35273409
- PMCID: PMC8903789
- DOI: 10.1080/01658107.2021.1984540
Course and Predictors of Visual Outcome of Idiopathic Intracranial Hypertension
Abstract
Idiopathic intracranial hypertension (IIH) is a clinical syndrome characterised by headache and papilloedema that can lead to significant visual morbidity. There are few studies in the literature about the visual outcome of IIH. We have reviewed the record of 76 patients with IIH according to the modified Dandy criteria. There was a significant improvement in the Humphrey 24-2 mean deviation (MD) in the study eyes (worse affected eye at presentation) in both the medically treated group (+2.0 dB; from -5.60 dB at baseline to -3.60 dB at final follow-up, p < .01) and in the fellow eyes in the medically treated group (+1.70 dB, from -4.40 dB at baseline to -2.74 dB at final follow-up, p < .01). Higher papilloedema grade (beta -0.66, p < .001) and age (p < .02) were inversely correlated with the final visual field MD in the study eye. The visual outcome for the IIH patients in our study was predominantly favourable, but patients with high-grade papilloedema had a worse visual prognosis and required more aggressive treatment.
Keywords: Idiopathic intracranial hypertension; Pseudotumor cerebri; visual outcome.
© 2021 Taylor & Francis Group, LLC.
Similar articles
-
Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.JAMA. 2014 Apr 23-30;311(16):1641-51. doi: 10.1001/jama.2014.3312. JAMA. 2014. PMID: 24756514 Free PMC article. Clinical Trial.
-
Visual Field Pointwise Analysis of the Idiopathic Intracranial Hypertension Weight Trial (IIH:WT).Transl Vis Sci Technol. 2023 May 1;12(5):1. doi: 10.1167/tvst.12.5.1. Transl Vis Sci Technol. 2023. PMID: 37126336 Free PMC article. Clinical Trial.
-
Ventriculoperitoneal shunt as a treatment of visual loss in idiopathic intracranial hypertension.J Neuroophthalmol. 2014 Sep;34(3):223-8. doi: 10.1097/WNO.0000000000000106. J Neuroophthalmol. 2014. PMID: 24637911
-
A systematic review of surgical treatments of idiopathic intracranial hypertension (IIH).Neurosurg Rev. 2021 Apr;44(2):773-792. doi: 10.1007/s10143-020-01288-1. Epub 2020 Apr 25. Neurosurg Rev. 2021. PMID: 32335853
-
Retinal Manifestations of Idiopathic Intracranial Hypertension.Ophthalmol Retina. 2021 May;5(5):429-437. doi: 10.1016/j.oret.2020.08.016. Epub 2020 Aug 26. Ophthalmol Retina. 2021. PMID: 32860958 Review.
Cited by
-
An interdisciplinary integrated specialized one-stop outpatient clinic for idiopathic intracranial hypertension-a comprehensive assessment of clinical outcome.Eur J Neurol. 2024 Oct;31(10):e16401. doi: 10.1111/ene.16401. Epub 2024 Aug 16. Eur J Neurol. 2024. PMID: 39152571 Free PMC article.
-
Factors associated with vision loss in idiopathic intracranial hypertension patients with severe papilledema.Eye (Lond). 2025 Jan;39(1):185-191. doi: 10.1038/s41433-024-03408-3. Epub 2024 Oct 30. Eye (Lond). 2025. PMID: 39478195
-
Predictors of Headaches and Quality of Life in Women with Ophthalmologically Resolved Idiopathic Intracranial Hypertension.J Clin Med. 2024 Jul 7;13(13):3971. doi: 10.3390/jcm13133971. J Clin Med. 2024. PMID: 38999535 Free PMC article.
-
Longitudinal visual outcomes in idiopathic intracranial hypertension: the role of early prognostic indicators and risk stratification in disease management.J Neurol. 2025 Jan 15;272(2):108. doi: 10.1007/s00415-024-12859-3. J Neurol. 2025. PMID: 39812855
References
LinkOut - more resources
Full Text Sources
Miscellaneous